Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
sábado, octubre 17
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
SkinHealth Systems Inc
SKIN
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$10.56
-2.04
-16.19%
Últ. Act.: Oct 15, 8:07 AM
$11.20
-1.40
-11.11%
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Opciones
Informe de acciones
Privacy Manager
División de acciones:
Se espera que SkinHealth Systems Inc se divida Wednesday, October 14, 2026 con una proporción de 1:20
SkinHealth Systems Financials
SkinHealth Systems (SKIN) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Beauty Health Sees Q3 Sales $65.000M-$70.000M vs $69.220M Est
Beauty Health (NASDAQ:SKIN) sees Q3 sales of $65.000 million-$70.000 million vs $69.220 million analyst estimate.
Benzinga Newsdesk
PRO
Beauty Health Narrows FY2026 Sales Guidance from $280.000M-$295.000M to $280.000M-$290.000M vs $289.529M Est
Beauty Health (NASDAQ:SKIN) narrows FY2026 sales outlook from $280.000 million-$295.000 million to $280.000 million-$290.000 million vs $289.529 million estimate.
Benzinga Newsdesk
PRO
Beauty Health Q2 EPS $(0.02), Inline, Sales $72.100M Miss $74.294M Estimate
Beauty Health (NASDAQ:SKIN) reported quarterly losses of $(0.02) per share which met the analyst consensus estimate. This is a 166.67 percent decrease over earnings of $0.03 per share from the same period last year.
Benzinga Newsdesk
PRO
Beauty Health Sees Q2 Sales $72.000M-$77.000M vs $76.764M Est
Beauty Health (NASDAQ:SKIN) sees Q2 sales of $72.000 million-$77.000 million vs $76.764 million analyst estimate.
Benzinga Newsdesk
PRO
Beauty Health Lowers FY2026 Sales Guidance from $285.000M-$305.000M to $280.000M-$295.000M vs $297.498M Est
Beauty Health (NASDAQ:SKIN) lowers FY2026 sales outlook from $285.000 million-$305.000 million to $280.000 million-$295.000 million vs $297.498 million estimate.
Benzinga Newsdesk
PRO
Beauty Health Q1 EPS $(0.05) Beats $(0.07) Estimate, Sales $64.900M Miss $66.448M Estimate
Beauty Health (NASDAQ:SKIN) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.07) by 28.57 percent. This is a 37.5 percent increase over losses of $(0.08) per share from the
Benzinga Newsdesk
